Prevest Denpro Quarterly Results for Trading Insights

In Sept 2025, Prevest Denpro (PREVEST) reported revenue ₹20 Cr and net profit ₹6 Cr — revenue +17.6% YoY. For annual financials, live price and key ratios, visit Prevest Denpro stock price NSE .

Latest Quarter Net Profit
₹6 Cr
QSept 2025
Quarterly Results

PREVEST Quarterly Results — Revenue, Profit & EPS Highlights

Prevest Denpro latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with PREVEST fundamental valuation to assess whether the stock is under or overvalued.

  • Revenue of ₹20 Cr in Sept 2025 (+0.0% vs Mar 2025, +17.6% vs Sept 2024)
  • Net Profit of ₹6 Cr in Sept 2025 (+20.0% vs Mar 2025, +20.0% vs Sept 2024)
  • EBITDA of ₹8 Cr in Sept 2025 (+0.0% vs Mar 2025)
  • Operating Margin of 36.0% in Sept 2025 (+1.0pp vs Mar 2025)
  • Earnings Per Share of ₹4.62 in Sept 2025 (+7.9% vs Mar 2025)

Prevest Denpro Quarterly Results — Revenue, EBITDA, Net Profit & EPS

PREVEST quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 20 20 17 20 17 - 17.6%
Net Profit (₹ Cr) 6 5 4 5 5 - -
EBITDA (₹ Cr) 8 8 7 7 7 - -
EPS (₹) 4.62 4.28 3.67 3.93 4.01 - -
Operating Margin (%) 36.0% 35.0% 34.0% 31.0% 36.0% - -

PREVEST Share Price Trend — 1-Year Movement Across Quarterly Results

Prevest Denpro 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse Prevest Denpro ownership structure to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 30.0%
EBITDA Margin 40.0%
Operating Margin 36.0%
ROE (Annual) 22.6%

Balance Sheet Highlights

Total Assets ₹113 Cr
Total Equity ₹106 Cr
Current Assets ₹86 Cr
Current Liabilities ₹1 Cr

Cash Flow Analysis

Operating Cash Flow ₹15 Cr
Investing Cash Flow ₹-1 Cr
Financing Cash Flow ₹-1 Cr
Net Cash Flow ₹12 Cr

Revenue Trend (₹ Cr)

Dec 2025 20
Jun 2025 17
Mar 2025 20
Sept 2025 20

Net Profit Trend (₹ Cr)

Dec 2025 5
Jun 2025 4
Mar 2025 5
Sept 2025 6

Operating Margin Trend (%)

Dec 2025 31.0%
Jun 2025 34.0%
Mar 2025 35.0%
Sept 2025 36.0%

PREVEST vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Prevest Denpro latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹396,418.12 Cr 1693.1 14,875 3,125 +10.8% - 21.0% 130.2
Divis Laboratories
Sept 2025 		₹161,139.43 Cr 6293.5 2,860 689 +7.1% - 24.1% 242.3
Torrent Pharmaceuti…
Sept 2025 		₹140,630.85 Cr 4155.9 3,219 591 +11.3% - 18.4% 236.9
Lupin
Sept 2025 		₹106,664.75 Cr 2327.0 6,921 1,485 +23.2% - 21.5% 71.9
Dr Reddys Laborator…
Sept 2025 		₹103,153.53 Cr 1221.4 9,135 1,337 +1.1% - 14.6% 75.5
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores